BBCMF (Lir Life Sciences) Total Current Assets: $0.76 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Total Current Assets?

Lir Life Sciences BBCMF -80.00% 15 Total Current Assets is $0.76 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Lir Life Sciences's total current assets for the quarter that ended in Jan. 2026 was $0.76 Mil.


Lir Life Sciences  (OTCPK:BBCMF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Lir Life Sciences's Liquidation Value for the quarter that ended in Jan. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.669-0.057+0.75 * 0+0.5 * 0
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lir Life Sciences Total Current Assets Related Terms


Lir Life Sciences Total Current Assets Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Total Current Assets Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Total Current Assets
0.15 0.09

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Current Assets Get a 7-Day Free Trial 0.00 0.09 0.01 1.11 0.76
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Lir Life Sciences's Total Current Assets for the fiscal year that ended in Apr. 2025 is calculated as

Lir Life Sciences's Total Current Assets for the quarter that ended in Jan. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $0.76 Mil mean?
Lir Life Sciences (BBCMF) has a Total Current Assets of $0.76 Mil as of Jan. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors.
Is Lir Life Sciences' Total Current Assets too high?
Lir Life Sciences' current Total Current Assets is $0.76 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Total Current Assets compare to VRTX and REGN?
Lir Life Sciences' Total Current Assets of $0.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors. Lir Life Sciences's current Total Current Assets is $0.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Total Current Assets of $0.76 Mil. The current Total Current Assets is $0.76 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Total Current Assets is $0.76 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price